Halozyme Therapeutics, Inc., a biopharmaceutical technology company, was established in 1998 and is based in San Diego, California. The company's operations span globally, covering markets in the United States, Switzerland, Ireland, Belgium, and Japan. At the heart of Halozyme's offerings is its patented ENHANZE drug delivery technology.